P&T Journal’s Pharmacovigilance Column Features CredibleMeds in a Recent Article on Drug-Induced QT Prolongation and Torsades De Pointes
Aug 16, 2017, 3:38 PM
We’re excited to announce that CredibleMeds was recently featured as a trusted, informative resource in a recent article published in P&T Community’s Pharmacovigilance Forum. The article focuses on the many common medicines that may increase the risk of drug-induced QT Prolongation and Torsades de Pointes arrhythmia
Jul 22, 2017, 3:39 PM
Four New Drug Added to CredibleMeds® Lists and Mobile Apps for QTdrugs/DTA Lists
Jun 20, 2017, 3:54 PM
Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of the addition of Midostaurin (anti-cancer drug) to the Possible Risk (PR) List.
May 17, 2017, 3:55 PM
Because the safe use of the CredibleMeds® lists of medications requires that the user have the most up-to-date lists of drugs, we are informing you of these changes to the QTdrugs.org lists: 1. Add Ribociclib and Necitumumab to Possible Risk List 2. Remove Foscarnet from Possible Risk List
Apr 27, 2017, 3:57 PM
The following changes have been made to the CredibleMed's lists of drugs:
Apr 20, 2017, 3:58 PM
Following the successful launch of the app, Cardiology Today recently published an article in their newest edition featuring the new mobile offering for patients and healthcare providers, written by Dr. Ray Woosley, Founder of CredibleMeds.
Mar 14, 2017, 4:02 PM
Pilsicainide, terodiline, prothipendyl and ketanserin added to QTdrugs lists. Smartphone Apps available FREE.
Feb 5, 2017, 4:00 PM
AZCERT is pleased to announce that Smartphone Apps are now available at no cost in the Apple, Windows Mobile and Google App Stores
Jan 7, 2017, 4:04 PM
AZCERT is pleased to announce that Smartphone Apps are now available at no cost in the Apple and Google App Stores for the CredibleMeds lists of drugs that prolong QT.
Dec 30, 2016, 4:06 PM
Changes to QTdrugs lists: Olanzapine, droxidopa, melperone, romidepsin, bendamustine and terlipressin